VRDN
Viridian Therapeutics Inc
19.40$
+2.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 69.0% | 57.9% | 75.1% | 97.4% | 76.4% | 490.2% | 362.8% | 735.1% | 2,695.6% | 20.9% | 42.6% | 421.0% | 410.6% | 1.6% | |
| 31.0% | 42.1% | 24.9% | 2.6% | 23.6% | -390.2% | -262.8% | 100.0% | -2,595.6% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 5.1% | 2.2% | 6.8% | 39.5% | 26.6% | 490.2% | 362.8% | 780.0% | 2,695.6% | 1,919.9% | 5,693.8% | 50,880.6% | 78,892.1% | 478.4% | |
| 66.0% | 41.4% | 162.8% | 303.1% | 236.9% | 272.6% | 131.8% | 261.1% | 1,263.3% | 870.9% | 1,985.4% | 30,254.5% | 20,226.2% | 134.5% | |
| 101.2% | 52.4% | 186.2% | 443.4% | 313.5% | 762.8% | 494.5% | 1,041.0% | 7,916.8% | 2,790.8% | 7,679.2% | 81,135.0% | 99,118.2% | 612.9% | |
| -91.4% | -4.5% | -159.0% | -440.8% | -374.8% | -662.8% | -394.5% | -941.0% | -10,512.4% | -2,690.8% | -7,579.2% | -81,035.0% | -99,018.2% | -512.9% | |
| 36.1% | 45.5% | 23.7% | 5.6% | 2.8% | 9.6% | 10.4% | 18.7% | 48.4% | 0.1% | 27.4% | 588.2% | 1,008.6% | 7.0% | |
| -127.5% | -50.0% | -182.6% | -446.3% | -379.8% | -662.3% | -390.0% | -938.6% | -10,544.3% | -2,680.2% | -7,329.2% | -75,711.5% | -89,387.1% | -483.6% | |
| 72.3% | 45.5% | 23.7% | – | 2.8% | 2.4% | 15.0% | 12.3% | 25.6% | 0.1% | -250.0% | 5,911.8% | -89,387.1% | – | |
| -163.7% | -50.0% | -182.6% | -446.3% | -379.8% | -662.3% | -390.0% | -938.6% | -10,544.3% | -2,680.2% | -7,329.2% | -75,711.5% | -89,387.1% | -483.6% | |
| -88.1% | -1.1% | -155.6% | -433.5% | -374.8% | -645.0% | -376.2% | -913.5% | -3,836.2% | -2,676.0% | -7,287.4% | -74,957.0% | -87,967.9% | -475.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.